>> I don't remember anybody trying to dispute it, grudgingly admitting it because they couldn't deny
>> it any more, nor do I ever remember it being a rumour.
My recollection is that the issue came to light via the UK's Yellow Card system for reporting side effects and similar systems in other countries. Given the very low numbers, new emerging evidence etc, there was inevitably a period where the issue, its significance and the group(s) affected was assessed.
As might be expected different countries, including those in the EU, reacted in their own ways with some more risk averse than others.
No reluctance, no grudging just dealing with emerging science.
|